Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations

Annals of Neurology

Volumn 77, Issue 4, 2015, Pages 675-683

  Baulac, Stéphanie ^a,b,c,d   Ishida, Saeko ^a,b,c,d   Marsan, Elise ^a,b,c,d   Miquel, Catherine ^e   Biraben, Arnaud ^f,g   Nguyen, Dang Khoa ^h   Nordli, Doug ⁱ   Cossette, Patrick ^h,j   Nguyen, Sylvie ^k   Lambrecq, Virginie ^a,b,c,d   Vlaicu, Mihaela ^d   Daniau, Maïlys ^a,b,c,d   Bielle, Franck ^a,b,c,d   Andermann, Eva ^l,m   Andermann, Frederick ^l,m   Leguern, Eric ^a,b,c,d   Chassoux, Francine ^b,e   Picard, Fabienne ⁿ  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CNRS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e CENTRE HOSPITALIER SAINTE ANNE   (France)

^f UNIVERSITÉ DE RENNES 1   (France)

^g UNIVERSITÉ DE RENNES 1   (France)

^h CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j UNIVERSITY OF MONTREAL   (Canada)

^k UNIVERSITÉ D'ANGERS   (France)

^l MCGILL UNIVERSITY   (Canada)

^m MCGILL UNIVERSITY   (Canada)

ⁿ GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEP DOMAIN CONTAINING PROTEIN 5; DNA; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; DEPDC5 PROTEIN, HUMAN; REPRESSOR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN BIOPSY; CHILD; CLINICAL ARTICLE; CORTICAL DYSPLASIA; DISEASE ASSOCIATION; FEMALE; FOCAL EPILEPSY; GENE MUTATION; GERMLINE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; EPILEPSIES, PARTIAL; GENETICS; MALFORMATIONS OF CORTICAL DEVELOPMENT; MUTATION; PEDIGREE; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MIDDLE AGED; MUTATION; PEDIGREE; REPRESSOR PROTEINS; YOUNG ADULT;

EID: 84925430981     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24368     Document Type: Article

References (39)

1. Baulac S,. Genetics advances in autosomal dominant focal epilepsies: focus on DEPDC5. Prog Brain Res 2014; 213: 123-139.
2. Steinlein OK,. Genetic heterogeneity in familial nocturnal frontal lobe epilepsy. Prog Brain Res 2014; 213: 1-15.
3. Muhlebner A, Coras R, Kobow K, et al. Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI. Acta Neuropathol 2012; 123: 259-272.
4. Sisodiya SM,. Malformations of cortical development: burdens and insights from important causes of human epilepsy. Lancet Neurol 2004; 3: 29-38.
5. Chassoux F, Devaux B, Landre E, et al. Stereoelectroencephalography in focal cortical dysplasia: a 3D approach to delineating the dysplastic cortex. Brain 2000; 123 (pt 8): 1733-1751.
6. Chassoux F, Landre E, Mellerio C, et al. Type II focal cortical dysplasia: electroclinical phenotype and surgical outcome related to imaging. Epilepsia 2012; 53: 349-358.
7. Spreafico R, Blumcke I,. Focal cortical dysplasias: clinical implication of neuropathological classification systems. Acta Neuropathol 2010; 120: 359-367.
8. Blumcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia 2011; 52: 158-174.
9. Leventer RJ, Jansen FE, Mandelstam SA, et al. Is focal cortical dysplasia sporadic? Family evidence for genetic susceptibility. Epilepsia 2014; 55: e22-e26.
10. Sisodiya SM, Fauser S, Cross JH, Thom M,. Focal cortical dysplasia type II: biological features and clinical perspectives. Lancet Neurol 2009; 8: 830-843.
11. Dibbens LM, de Vries B, Donatello S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet 2013; 45: 546-551.
12. Ishida S, Picard F, Rudolf G, et al. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet 2013; 45: 552-555.
13. Picard F, Makrythanasis P, Navarro V, et al. DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. Neurology 2014; 82: 2101-2106.
14. Lal D, Reinthaler EM, Schubert J, et al. DEPDC5 mutations in genetic focal epilepsies of childhood. Ann Neurol 2014; 75: 788-792.
15. Scheffer IE, Heron SE, Regan BM, et al. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol 2014; 75: 782-787.
16. Bar-Peled L, Chantranupong L, Cherniack AD, et al. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 2013; 340: 1100-1106.
17. Panchaud N, Peli-Gulli MP, De Virgilio C,. Amino acid deprivation inhibits TORC1 through a GTPase-activating protein complex for the rag family GTPase Gtr1. Sci Signal 2013; 6: ra42.
18. Laplante M, Sabatini DM,. mTOR signaling in growth control and disease. Cell 2012; 149: 274-293.
19. Lim KC, Crino PB,. Focal malformations of cortical development: new vistas for molecular pathogenesis. Neuroscience 2013; 252: 262-276.
20. Crino PB,. Evolving neurobiology of tuberous sclerosis complex. Acta Neuropathol 2013; 125: 317-332.
21. Parker WE, Orlova KA, Parker WH, et al. Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder. Sci Transl Med 2013; 5: 182ra53.
22. Lee JH, Huynh M, Silhavy JL, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012; 44: 941-945.
23. Lasarge CL, Danzer SC,. Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation. Front Mol Neurosci 2014; 7: 18.
24. Picard F, Baulac S, Kahane P, et al. Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families. Brain 2000; 123 (pt 6): 1247-1262.
25. Gallagher A, Lassonde M, Bastien D, et al. Non-invasive pre-surgical investigation of a 10 year-old epileptic boy using simultaneous EEG-NIRS. Seizure 2008; 17: 576-582.
26. Poduri A,. DEPDC5 does it all: shared genetics for diverse epilepsy syndromes. Ann Neurol 2014; 75: 631-633.
27. Mellerio C, Labeyrie MA, Chassoux F, et al. Optimizing MR imaging detection of type 2 focal cortical dysplasia: best criteria for clinical practice. AJNR Am J Neuroradiol 2012; 33: 1932-1938.
28. Nobili L, Cardinale F, Magliola U, et al. Taylor's focal cortical dysplasia increases the risk of sleep-related epilepsy. Epilepsia 2009; 50: 2599-2604.
29. Hong SJ, Kim H, Schrader D, et al. Automated detection of cortical dysplasia type II in MRI-negative epilepsy. Neurology 2014; 83: 48-55.
30. Ryvlin P, Cross JH, Rheims S,. Epilepsy surgery in children and adults. Lancet Neurol 2014; 13: 1114-1126.
31. Chassoux F, Rodrigo S, Semah F, et al. FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias. Neurology 2010; 75: 2168-2175.
32. Marini C, Guerrini R,. The role of the nicotinic acetylcholine receptors in sleep-related epilepsy. Biochem Pharmacol 2007; 74: 1308-1314.
33. Costa-Mattioli M, Monteggia LM,. mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci 2013; 16: 1537-1543.
34. Crino PB,. mTOR: A pathogenic signaling pathway in developmental brain malformations. Trends Mol Med 2011; 17: 734-742.
35. Marin-Valencia I, Guerrini R, Gleeson JG,. Pathogenetic mechanisms of focal cortical dysplasia. Epilepsia 2014; 55: 970-978.
36. Poduri A, Evrony GD, Cai X, Walsh CA,. Somatic mutation, genomic variation, and neurological disease. Science 2013; 341: 1237758.
37. Depienne C, Trouillard O, Gourfinkel-An I, et al. Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome. J Med Genet 2010; 47: 404-410.
38. Crino PB, Aronica E, Baltuch G, Nathanson KL,. Biallelic TSC gene inactivation in tuberous sclerosis complex. Neurology 2010; 74: 1716-1723.
39. Jamuar SS, Lam AT, Kircher M, et al. Somatic mutations in cerebral cortical malformations. N Engl J Med 2014; 371: 733-743.